Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a highly malignant human cancer that has increasing mortality rates worldwide. Because CD133(+) cells control tumor maintenance and progression, compounds that target CD133(+) cancer cells could be effective in combating HCC. We found that the administration of chro...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yeonhwa, Kim, Sanghwa, Lee, Hyeryon, No, Joo Hwan, Ryu, Hyung Chul, Kim, Jason, Lim, Jee Woong, Kim, Moonhee, Choi, Inhee, Seo, Haeng Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281429/
https://www.ncbi.nlm.nih.gov/pubmed/32397206
http://dx.doi.org/10.3390/cancers12051193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281429/
https://www.ncbi.nlm.nih.gov/pubmed/32397206
http://dx.doi.org/10.3390/cancers12051193

Ejemplares similares